BlackRock Investment Management’s XBiotech XBIT Stock Holding History

BlackRock Investment Management’s Portfolio XBIT Stock Details XBIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$682K	Buy	67,378 +421	+0.6%	+$5.6K	﹤0.01%	2910
2016 Q3	$901K	Sell	66,957 -129	-0.2%	-$1.89K	﹤0.01%	2745
2016 Q2	$1.4M	Buy	67,086 +52,881	+372%	+$763K	﹤0.01%	2388
2016 Q1	$134K	Buy	14,205 +256	+2%	+$2.12K	﹤0.01%	3210
2015 Q4	$152K	Hold	13,949	–	–	﹤0.01%	3251
2015 Q3	$208K	Sell	13,949 -284	-2%	-$4.97K	﹤0.01%	3243
2015 Q2	$257K	Buy	+14,233	New	+$295K	﹤0.01%	3242

Other funds holding XBIT

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock Investment Management's XBIT Position: Q4 2016 in Review

BlackRock Investment Management increased its XBiotech (XBIT) stake by 0.63% in Q4 2016, buying an estimated $5.6K and bringing the position to 67,378 shares worth $682K. The position accounts for ﹤0.01% of the portfolio, ranked #2910.

BlackRock Investment Management first reported a position in XBIT in Q2 2015 and has held it in 7 quarters since. The position peaked at $1.4M in Q2 2016. 49 funds tracked by Wall St. Rank hold XBIT as of Q4 2016.

BlackRock Investment Management held 67,378 shares of XBiotech worth $682K as of Q4 2016.
BlackRock Investment Management bought 421 XBiotech shares in Q4 2016, an estimated $5.6K.
XBiotech made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #2910 holding.
BlackRock Investment Management first reported a position in XBiotech in Q2 2015 and has held it in 7 quarters since.
BlackRock Investment Management's XBiotech position peaked at $1.4M in Q2 2016.
49 funds tracked by Wall St. Rank held XBiotech as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.